DrugCite
Search

LEXISCAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Lexiscan Adverse Events Reported to the FDA Over Time

How are Lexiscan adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lexiscan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lexiscan is flagged as the suspect drug causing the adverse event.

Most Common Lexiscan Adverse Events Reported to the FDA

What are the most common Lexiscan adverse events reported to the FDA?

Nausea
100 (5.11%)
Dyspnoea
67 (3.42%)
Headache
55 (2.81%)
Dizziness
46 (2.35%)
Hypotension
46 (2.35%)
Unresponsive To Stimuli
46 (2.35%)
Vomiting
43 (2.2%)
Hypertension
42 (2.15%)
Chest Pain
40 (2.04%)
Loss Of Consciousness
40 (2.04%)
Bradycardia
38 (1.94%)
Show More Show More
Cardiac Arrest
33 (1.69%)
Heart Rate Increased
33 (1.69%)
Pain In Extremity
31 (1.58%)
Convulsion
30 (1.53%)
Flushing
26 (1.33%)
Syncope
25 (1.28%)
Chest Discomfort
23 (1.18%)
Diarrhoea
21 (1.07%)
Hyperhidrosis
21 (1.07%)
Respiratory Arrest
21 (1.07%)
Blood Pressure Decreased
20 (1.02%)
Tremor
19 (.97%)
Muscle Spasms
17 (.87%)
Blood Pressure Increased
16 (.82%)
Arthralgia
15 (.77%)
Feeling Abnormal
15 (.77%)
Malaise
15 (.77%)
Myocardial Infarction
15 (.77%)
Death
14 (.72%)
Acute Myocardial Infarction
13 (.66%)
Asthenia
13 (.66%)
Electrocardiogram Qt Prolonged
13 (.66%)
Heart Rate Decreased
13 (.66%)
Hypoaesthesia
13 (.66%)
Abdominal Pain
12 (.61%)
Atrioventricular Block Complete
12 (.61%)
Fatigue
12 (.61%)
Ventricular Extrasystoles
12 (.61%)
Aphasia
11 (.56%)
Myocardial Ischaemia
11 (.56%)
Cerebrovascular Accident
10 (.51%)
Paraesthesia
10 (.51%)
Angioedema
9 (.46%)
Anxiety
9 (.46%)
Electrocardiogram St Segment Depres...
9 (.46%)
Fall
9 (.46%)
Hypersensitivity
9 (.46%)
Migraine
9 (.46%)
Retching
9 (.46%)
Wheezing
9 (.46%)
Anaphylactic Reaction
8 (.41%)
Cardio-respiratory Arrest
8 (.41%)
Myalgia
8 (.41%)
Off Label Use
8 (.41%)
Pain
8 (.41%)
Presyncope
8 (.41%)
Supraventricular Extrasystoles
8 (.41%)
Acute Pulmonary Oedema
7 (.36%)
Pallor
7 (.36%)
Pulmonary Oedema
7 (.36%)
Abdominal Discomfort
6 (.31%)
Agitation
6 (.31%)
Anaemia
6 (.31%)
Atrial Fibrillation
6 (.31%)
Back Pain
6 (.31%)
Bundle Branch Block Right
6 (.31%)
Drug Hypersensitivity
6 (.31%)
Dysarthria
6 (.31%)
Dysphagia
6 (.31%)
Electrocardiogram Change
6 (.31%)
Facial Palsy
6 (.31%)
No Therapeutic Response
6 (.31%)
Rash
6 (.31%)
Sensation Of Heaviness
6 (.31%)
Sinus Arrest
6 (.31%)
Sinus Bradycardia
6 (.31%)
Transient Ischaemic Attack
6 (.31%)
Amnesia
5 (.26%)
Arteriospasm Coronary
5 (.26%)
Atrioventricular Block First Degree
5 (.26%)
Bronchospasm
5 (.26%)
Cardiac Failure Congestive
5 (.26%)
Cough
5 (.26%)
Haemorrhage
5 (.26%)
Incoherent
5 (.26%)
Infusion Site Pain
5 (.26%)
Muscular Weakness
5 (.26%)
Palpitations
5 (.26%)
Stress
5 (.26%)
Ventricular Tachycardia
5 (.26%)
Vision Blurred
5 (.26%)
Abdominal Pain Upper
4 (.2%)
Aggression
4 (.2%)
Blood Pressure Systolic Increased
4 (.2%)
Cardiovascular Disorder
4 (.2%)
Conversion Disorder
4 (.2%)
Coronary Artery Stenosis
4 (.2%)
Depressed Level Of Consciousness
4 (.2%)
Electrocardiogram St-t Change
4 (.2%)
Gait Disturbance
4 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Lexiscan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lexiscan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lexiscan

What are the most common Lexiscan adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lexiscan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lexiscan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Lexiscan According to Those Reporting Adverse Events

Why are people taking Lexiscan, according to those reporting adverse events to the FDA?

Scan Myocardial Perfusion
396
Cardiac Stress Test
60
Product Used For Unknown Indication
23
Drug Use For Unknown Indication
18
Chest Pain
10
Cardiac Imaging Procedure
5
Show More Show More
Coronary Artery Disease
3
Electrocardiogram Abnormal
2
Dyspnoea
2
Surgery
2
Cardiac Pharmacologic Stress Test
2
Positron Emission Tomogram
2
Diagnostic Procedure
2
Cardiovascular Disorder
2
Stress
1
Cardiomyopathy
1
Cardiac Failure Congestive
1
Preoperative Care
1
Abasia
1
Hypertension
1
Hypotension
1
Ischaemia
1
Single Photon Emission Computerised...
1

Drug Labels

LabelLabelerEffective
LexiscanAstellas Pharma US, Inc.30-JUL-12

Lexiscan Case Reports

What Lexiscan safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Lexiscan. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Lexiscan.